| Janet Hemingway | |
| Birth Date: | 1957 6, df=yes |
| Birth Place: | West Yorkshire |
| Workplaces: | Liverpool School of Tropical Medicine |
| Thesis Title: | Genetics and biochemistry of insecticide resistance in Anophelines |
| Thesis Url: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.245379 |
| Thesis Year: | 1981 |
| Awards: |
|
Janet Hemingway (born 1957)[1] is a British infectious diseases specialist. She is the former Director of Liverpool School of Tropical Medicine (LSTM) and founding Director of Infection Innovation Consortium and Professor of Tropical Medicine at LSTM.[2] She is currently the President of the Royal Society of Tropical Medicine and Hygiene. [3]
While serving as Director of LSTM between 2001 and 2019, the organization hit several milestones. This included the awarding of Higher Education Institution Status & Degree Awarding powers to LSTM. For her 2012 contributions to the Prevention of Tropical Disease Vectors, she received the Commander of the British Empire (CBE). She assumed the role of founding director of iiCON in 2020.
Hemingway also works on advocacy and resource mobilization (and was previously chief executive officer) at the Innovative Vector Control Consortium (IVCC) (funded by the Bill and Melinda Gates Foundation),[4] and is International Director of the Joint Centre for Infectious Diseases Research, Jizan, Saudi Arabia.[5]
Hemingway was born in a small mining town in West Yorkshire in 1957 to parents who owned a corner shop. She obtained a first-class honors degree in zoology and genetics from the University of Sheffield, where she set up the university's first mosquito insectary as part of her thesis project. She was invited to pursue a PhD at the London School of Hygiene and Tropical Medicine (LSHTM), and obtained her doctorate after two years of studying the biochemistry and genetics of insecticide resistance in Anopheles mosquitoes.[1] [6] [7]
Hemingway has worked on the biochemistry and molecular biology of specific enzyme systems associated with xenobiotic resistance, most notably the malaria-transmitting mosquito, for over 30 years.[8] [9] [10] [11]
Hemingway is distinguished as the international authority on insecticide resistance in insect vectors of disease. She was first to report co-amplification of multiple genes on a single amplicon and demonstrate their impact on disease transmission. Her studies on resistance management have transformed the use of insecticide by disease control programs. Her promotion of evidence-based monitoring and evaluation strategies for insecticide resistance has guided and improved international policy on vector control strategies for Onchocerciasis, Malaria, and other vector borne diseases. Her rigorous scientific approach to resistance analysis has contributed to a greater understanding of resistance, its impact and spread and has minimized its effect in increasing human mortality and morbidity.